What’s driving demand for cortisone (steroid) shots?
Cortisone shots (typically corticosteroid injections into joints or tissues) are used to reduce pain and inflammation in conditions such as osteoarthritis and other musculoskeletal disorders. Demand tends to track growth in arthritis prevalence and the volume of outpatient orthopedic and pain-management care.
Key demand drivers
- Rising burden of osteoarthritis and joint pain, which increases the number of injections prescribed in outpatient settings.
- Growth of imaging-guided procedures (for example, ultrasound or fluoroscopy) that improve targeting and may support repeat use.
- Preference for non-surgical, symptom-relief options in patients who delay or avoid surgery.
How fast is the cortisone shots market growing, and what segments matter most?
Market performance is usually analyzed by product and by indication/site of injection (such as knee, shoulder, hip, spine/epidural spaces), plus by geography and end user (hospitals vs. ambulatory surgery centers vs. specialty clinics).
Segments users typically look at
- By injection site (knee and shoulder are often among the largest volumes in practice)
- By indication (osteoarthritis, bursitis, tendinitis, synovitis, and spine-related inflammation can have different growth patterns)
- By setting (hospital outpatient and ambulatory clinics often dominate administration volume for routine injections)
Are there “bigger” markets than cortisone shots—like alternative injection therapies?
In many orthopedic markets, corticosteroid injections compete with other non-surgical options, especially:
- Hyaluronic acid (viscosupplementation) for knee pain
- Platelet-rich plasma (PRP) for selected indications
- Physical therapy and other conservative care pathways that may reduce injection frequency
Whether corticosteroids lose or hold share depends on payer coverage, guideline positioning for each indication, patient preference, and relative outcomes in each subgroup.
What are the main risks that affect adoption and patient demand?
Cortisone shots are widely used, but adoption can be influenced by safety concerns and clinical guidance on frequency.
Patient and clinician concerns that show up in market demand
- Short-term side effects (for example, injection-site pain, transient blood-sugar increases in people with diabetes)
- Risk discussions around repeated use and appropriate spacing
- Steroid-specific warnings depending on injection type and anatomical site (for example, intra-articular vs. epidural)
These concerns can affect how often patients seek injections and how providers counsel on timing.
How do pricing and reimbursement shape the market?
The market is strongly affected by reimbursement policies for office-based injections and outpatient procedure billing. Coverage rules can determine whether injections are used for certain indications, how frequently they are allowed, and what products are preferred.
Things analysts typically track
- Tendering and procurement pricing for injectable formulations
- Differences in reimbursement between hospital outpatient departments and ambulatory settings
- Utilization management (limits on frequency, documentation requirements)
What competitive landscape issues matter (brands, generics, and litigation)?
Cortisone products include multiple corticosteroid formulations and brands that can face generic competition. Competitive dynamics often depend on:
- Product availability and contracting with provider groups
- Clinical preference by formulation, delivery method, and guidance for specific injection sites
- Patent/litigation timelines for branded products (where applicable)
How long is the “typical” use cycle for cortisone injections?
Cortisone shots are often not one-and-done. Patients may receive repeat injections based on symptom recurrence, response duration, and provider guidance. This makes the market sensitive to:
- Average time-to-relapse after injection
- Provider practice patterns on repeat dosing
- Long-term shifts toward surgery or alternative biologic/non-steroid strategies
What to ask next if you want a full market analysis
To produce a useful investment-ready or business-ready analysis, you typically need the scope definition:
- Which geography (US, EU5, China, global)?
- Which segment (knee OA only, all joints, epidural space, or all corticosteroid injections)?
- Which product set (specific corticosteroids or all steroid injections)?
- What output you want (TAM/SAM/SOM sizing, CAGR, competitive share, pricing trends, regulatory outlook)?
If you tell me the geography and timeframe you care about (for example, 2024–2030, US only, all indications), I can structure the analysis around those exact segments and metrics.